Abstract:Abstract Alzheimer’s disease (AD) is the most common type of dementia. Its diagnosis and progression detection have been intensively studied. Nevertheless, research studies often have little effect on clinical practice mainly due to the following reasons: (1) Most studies depend mainly on a single modality, especially neuroimaging; (2) diagnosis and progression detection are usually studied separately as two independent problems; and (3) current studies concentrate mainly on optimizing the performance of complex machine learning models, while disregarding their explainability. As a result, physicians struggle to interpret these models, and feel it is hard to trust them. In this paper, we carefully develop an accurate and interpretable AD diagnosis and progression detection model. This model provides physicians with accurate decisions along with a set of explanations for every decision. Specifically, the model integrates 11 modalities of 1048 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) real-world dataset: 294 cognitively normal, 254 stable mild cognitive impairment (MCI), 232 progressive MCI, and 268 AD. It is actually a two-layer model with random forest (RF) as classifier algorithm. In the first layer, the model carries out a multi-class classification for the early diagnosis of AD patients. In the second layer, the model applies binary classification to detect possible MCI-to-AD progression within three years from a baseline diagnosis. The performance of the model is optimized with key markers selected from a large set of biological and clinical measures. Regarding explainability, we provide, for each layer, global and instance-based explanations of the RF classifier by using the SHapley Additive exPlanations (SHAP) feature attribution framework. In addition, we implement 22 explainers based on decision trees and fuzzy rule-based systems to provide complementary justifications for every RF decision in each layer. Furthermore, these explanations are represented in natural language form to help physicians understand the predictions. The designed model achieves a cross-validation accuracy of 93.95% and an F1-score of 93.94% in the first layer, while it achieves a cross-validation accuracy of 87.08% and an F1-Score of 87.09% in the second layer. The resulting system is not only accurate, but also trustworthy, accountable, and medically applicable, thanks to the provided explanations which are broadly consistent with each other and with the AD medical literature. The proposed system can help to enhance the clinical understanding of AD diagnosis and progression processes by providing detailed insights into the effect of different modalities on the disease risk.

Explainable Artificial Intelligence Based on Feature Optimization for Age at Onset Prediction of Spinocerebellar Ataxia Type 3.

Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning

New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3

Visual Prediction of the Progression of Spinocerebellar Ataxia Type 3 Based on Machine Learning

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

The Progression Rate of Spinocerebellar Ataxia Type 3 Varies with Disease Stage

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study

Potential Fluid Biomarkers and a Prediction Model for Better Recognition Between Multiple System Atrophy-Cerebellar Type and Spinocerebellar Ataxia

(Cag)n Loci As Genetic Modifiers of Age at Onset in Patients with Spinocerebellar Ataxia Type 1 from Mainland China.

The APOE Ε2 Allele May Decrease the Age at Onset in Patients with Spinocerebellar Ataxia Type 3 or Machado-Joseph Disease from the Chinese Han Population

Two Novel SNPs in ATXN3 3' UTR May Decrease Age at Onset of SCA3/MJD in Chinese Patients.

Explainable Machine Learning with Pairwise Interactions for Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Utilizing Multi-Modalities Data

Predicting Alzheimer's Disease with Interpretable Machine Learning.

MACHINE-LEARNING-BASED INTERPRETABLE PREDICTION FOR MILD COGNITIVE IMPAIRMENT: FROM ADNI DATABASE

Explainable Machine Learning with Pairwise Interactions for Predicting Conversion from Mild Cognitive Impairment to Alzheimer's Disease Utilizing Multi-Modalities Data

Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer’s disease prediction

DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients

Age is an important independent modifier of SCA3 phenotype severity

A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease

Investigating Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease Based on Different Time Intervals

The utility of explainable A.I. for MRI analysis: Relating model predictions to neuroimaging features of the aging brain